<DOC>
	<DOCNO>NCT00119197</DOCNO>
	<brief_summary>The purpose study confirm safety immunogenicity oral kill bivalent cholera vaccine adult pediatric volunteer Eastern Kolkata , West Bengal , India .</brief_summary>
	<brief_title>Safety Immunogenicity Oral Cholera Vaccine Kolkata</brief_title>
	<detailed_description>Cholera remain serious public health problem worldwide . In mid-1980s follow technology transfer Sweden , Vietnamese scientist develop produce oral kill monovalent cholera vaccine Vietnam 's public health program . A 2-dose regimen vaccine show safe efficacious . Subsequently , bivalent vaccine develop contain newly emergent O139 V. cholerae . This vaccine several advantage exist Swedish vaccine . It confer protection El Tor biotype young child , considerably less expensive , require buff administration require strict cold chain requirement . However , vaccine license use country Vietnam . Through IVI , agreement VABIOTECH Hanoi Shantha Biotechnics PVT , LTD India reach make bivalent vaccine available India . A double-blind randomized phase III trial cholera-endemic area would necessary demonstrate efficacy vaccine setting . This would pave way introduction vaccine national immunization programme India internationalization vaccine licensure country need . Prior phase III trial , phase II study perform among adults child .</detailed_description>
	<mesh_term>Cholera</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy nonpregnant adult age 1840 year child age 117 year Diarrhea past week Antibiotic antidiarrheal medicine use past week One episodes diarrhea abdominal pain last 2 week past 6 month Abdominal pain , nausea , vomit , loss appetite generalize ill feel past 24 hour Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>watery diarrhea</keyword>
	<keyword>cholera vaccine</keyword>
</DOC>